Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs

被引：30

作者：

Yang, Huanjie ^{[2
,3
]}

Sun, Dong Kui ^{[1
]}

Chen, Di ^{[2
,3
]}

Cui, Qiuzhi Cindy ^{[2
,3
]}

Gu, Yan Yan ^{[1
]}

Jiang, Tao ^{[1
]}

Chen, Wei ^{[4
,5
]}

Wan, Sheng Biao ^{[1
]}

Dou, Q. Ping ^{[2
,3
]}

机构：

[1] Ocean Univ China, Key Lab Marine Drug, Minist Educ, Sch Med & Pharm, Qingdao, Peoples R China

[2] Wayne State Univ, Prevent Program, Barbara Ann Karmanos Canc Inst, Sch Med, Detroit, MI USA

[3] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA

[4] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[5] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA

来源：

CANCER LETTERS | 2010年 / 292卷 / 01期

关键词：

Breast cancer; Proteasome inhibitor; Drug discovery; Cancer prevention; Tea polyphenol; GREEN TEA CATECHINS; HUMAN PROSTATE-CANCER; PROTEASOME INHIBITORS; APOPTOSIS INDUCERS; POLYPHENOLS; METHYLATION; SUPPRESSES; THERAPY; TARGET; TRIAL;

D O I：

10.1016/j.canlet.2009.11.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epidemiological studies support the cancer-preventive effects of green tea and its main constituent (-)-epigallocatechin gallate [(-)-EGCG], however, (-)-EGCG is unstable under physiological conditions. Here we report that two novel fluoro-substituted (-)-EGCG analogs inhibited tumor growth with similar potency to that of Pro-EGCG (1) which has improved potency over parental compound (-)-EGCG in human breast cancer MDA-MB-231 xenografts. MDA-MB-231 tumors treated with each fluoro-substituted (-)-EGCG analog showed proteasome inhibition and apoptotic cell death, suggesting that the proteasome might be one of the cellular targets of fluoro-(-)-EGCGs and that proteasome inhibition is partially responsible for the observed antitumor activity. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：48 / 53

页数：6

共 50 条

[21] TLC separation of methylated (-)-epigallocatechin-3-gallate
Amarowicz, R
Maryniak, A
Shahidi, F
CZECH JOURNAL OF FOOD SCIENCES, 2005, 23 (01) : 36 - 39
[22] The Effect of (-)-Epigallocatechin-3-Gallate on the Aβ Secondary Structure
Acharya, Atanu
Stockmann, Julia
Beyer, Leon
Nabers, Andreas
Gerwert, Klaus
Gumbart, James C.
Batista, Victor S.
BIOPHYSICAL JOURNAL, 2020, 118 (03) : 47A - 47A
[23] Antioxidant Nanocomplexes for Delivery of Epigallocatechin-3-gallate
Hu, Bing
Ma, Fengguang
Yang, Yingkang
Xie, Minhao
Zhang, Chen
Xu, Ye
Zeng, Xiaoxiong
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2016, 64 (17) : 3422 - 3429
[24] Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate
Xie, Wen
Ramakrishna, Narayan
Wieraszko, Andrzej
Hwang, Yu-Wen
NEUROCHEMICAL RESEARCH, 2008, 33 (05) : 776 - 783
[25] Promotion of Neuronal Plasticity by (−)-Epigallocatechin-3-Gallate
Wen Xie
Narayan Ramakrishna
Andrzej Wieraszko
Yu-Wen Hwang
Neurochemical Research, 2008, 33 : 776 - 783
[26] Assessment of safety and embryotoxicity of (-)-Epigallocatechin-3-gallate
Rodriguez-Fragoso, Lourdes
Isabel Gonsaga-Morales, Ana
Reyes Esparza, Jorge
FASEB JOURNAL, 2012, 26
[27] Topical epigallocatechin-3-gallate in the treatment of vitiligo
Hu, Wenting
Zhang, Lingling
Lin, Fuquan
Lei, Jiehao
Zhou, Miaoni
Xu, AiE
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : E404 - E407
[28] A novel mechanism of action of(-)-epigallocatechin-3-gallate - activation of keratinocyte differentiation but not apoptosis
Balasubramanian, S
Sturniolo, MT
Eckert, R
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A71 - A71
[29] Design, semisynthesis, and evaluation of O-Acyl derivatives of (-)-epigallocatechin-3-gallate as antitumor agents
Vyas, Sandeep
Sharma, Manu
Sharma, Pritam D.
Singh, Tej V.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2007, 55 (15) : 6319 - 6324
[30] Epigallocatechin-3-gallate modulates arrhythmogenic activity and calcium homeostasis of left atrium
Chang, Jun-Hei
Chang, Shih-Lin
Hong, Po-Da
Chen, Ping-Nan
Hsu, Chih-Hsueng
Lu, Yen-Yu
Chen, Yao-Chang
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 174 - 180

← 1 2 3 4 5 →